Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Darla Liles"'
Autor:
Julie Kanter, Sarah Mennito, Santosh M. Nair, Deepa Manwani, Abdullah Kutlar, Nirmish Shah, Deborah Keefe, Hariprasad Madhamshetty, Michele Nassin, Evgeniya Reshetnyak, Anisha E. Mendonza, Darla Liles
Publikováno v:
Therapeutic Advances in Hematology, Vol 15 (2024)
Background: Crizanlizumab is a novel inhibitor of P-selectin, a key player in multicellular adhesion and inflammatory signaling, that leads to vaso-occlusion in sickle cell disease (SCD). Objectives: The SOLACE-adults study evaluated the pharmacokine
Externí odkaz:
https://doaj.org/article/1a16ace2d00e43cdb4f23e6352086cce
Autor:
Alan Anderson, Fuad El Rassi, Michael R. Debaun, Modupe Idowu, Julie Kanter, Soheir Adam, Susanna Curtis, Darla Liles, Biree Andemariam, Morgan L. Mclemore, Robert Sheppard Nickel, Poornima Ramadas, Jincy Paulose, Dram Laine, Mahmudul Khan, Deepika Darbari, Arthur L. Burnett
Publikováno v:
HemaSphere, Vol 7, p e54376db (2023)
Externí odkaz:
https://doaj.org/article/ff2f5e5713de48b881a6ba3fd4d4c1f6
Publikováno v:
Clinical Case Reports, Vol 11, Iss 8, Pp n/a-n/a (2023)
Key Clinical Message Acquired factor VIII inhibitors can be a rare cause of extensive intramuscular bleeding requiring fasciotomy. The subsequent postoperative period requires close monitoring due to high risk of fatal blood loss. Abstract Acquired f
Externí odkaz:
https://doaj.org/article/decb26a8126f40bbb19bb311f18e5983
Autor:
Margaret AM Nelson, Kelsey L McLaughlin, James T Hagen, Hannah S Coalson, Cameron Schmidt, Miki Kassai, Kimberly A Kew, Joseph M McClung, P Darrell Neufer, Patricia Brophy, Nasreen A Vohra, Darla Liles, Myles C Cabot, Kelsey H Fisher-Wellman
Publikováno v:
eLife, Vol 10 (2021)
Currently there is great interest in targeting mitochondrial oxidative phosphorylation (OXPHOS) in cancer. However, notwithstanding the targeting of mutant dehydrogenases, nearly all hopeful ‘mito-therapeutics’ cannot discriminate cancerous from
Externí odkaz:
https://doaj.org/article/e567853a8a3040149b87851b0c1938d3
Autor:
Abdul Rafeh Naqash, Ebenezer Appah, Li V. Yang, Mahvish Muzaffar, Mona A. Marie, Justin D. Mccallen, Shravanti Macherla, Darla Liles, Paul R. Walker
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-10 (2019)
Abstract Background Compared to conventional chemotherapy, Immune checkpoint inhibitors (ICI) are known to have a distinct toxicity profile commonly identified as immune-related adverse events (irAEs). These irAEs that are believed to be related to i
Externí odkaz:
https://doaj.org/article/8fb76ca2c40e4edd93e37771226ab1ae
Publikováno v:
BMC Research Notes, Vol 11, Iss 1, Pp 1-6 (2018)
Abstract Objective Adherence to oral chemotherapy is essential for patients with chronic myeloid leukemia (CML) and multiple myeloma (MM) to remain in remission. Few studies have used a Likert-type scale to measure medication adherence in CML and MM
Externí odkaz:
https://doaj.org/article/8f375efba5e0435eb21557cfce2a14d2
Publikováno v:
International Journal of Breast Cancer, Vol 2018 (2018)
Background. Inflammatory breast cancer (IBC) is a rare but most aggressive breast cancer subtype. The impact of locoregional therapy on survival in IBC is controversial. Methods. Patients with nonmetastatic IBC between 1988 and 2013 were identified i
Externí odkaz:
https://doaj.org/article/19255c51b96b422fbc110b784db4ba97
Autor:
Julie Kanter, R. Clark Brown, Cynthia Norris, Santosh M. Nair, Abdullah Kutlar, Deepa Manwani, Nirmish Shah, Chiaki Tanaka, Shankaranand Bodla, Gessami Sanchez-Olle, Urs Albers, Darla Liles
Publikováno v:
Blood Advances. 7:943-952
Crizanlizumab is an anti–P-selectin monoclonal antibody indicated to reduce the frequency/prevent recurrence of vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD) aged ≥16 years. This analysis of an ongoing phase 2, nonrandom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a0d8d9b6bc44660774018cebf9778b2
https://doi.org/10.1182/bloodadvances.2022008209
https://doi.org/10.1182/bloodadvances.2022008209
Autor:
Edward L. Snyder, Allison P. Wheeler, Majed Refaai, Claudia S. Cohn, Jessica Poisson, Magali Fontaine, Mary Sehl, Ajay K. Nooka, Lynne Uhl, Philip Spinella, Maly Fenelus, Darla Liles, Thomas Coyle, Joanne Becker, Michael Jeng, Eric A. Gehrie, Bryan R. Spencer, Pampee Young, Andrew Johnson, Jennifer J. O'Brien, Gary J. Schiller, John D. Roback, Elizabeth Malynn, Ronald Jackups, Scott T. Avecilla, Jin‐Sying Lin, Kathy Liu, Stanley Bentow, Ho‐Lan Peng, Jeanne Varrone, Richard J. Benjamin, Laurence M. Corash
Publikováno v:
Transfusion, vol 62, iss 7
BackgroundPlatelet transfusion carries risk of transfusion-transmitted infection (TTI). Pathogen reduction of platelet components (PRPC) is designed to reduce TTI. Pulmonary adverse events (AEs), including transfusion-related acute lung injury and ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54b7b7f52ca08c162d30c6a52008854f
https://doi.org/10.1111/trf.16987
https://doi.org/10.1111/trf.16987
Autor:
Alan Anderson, Fuad El Rassi, Michael R. DeBaun, Modupe Idowu, Julie Kanter, Soheir Adam, Susanna Curtis, Darla Liles, Biree Andemariam, Morgan L. McLemore, Robert Sheppard Nickel, Poornima Ramadas, Jincy Paulose, Dramane I Laine, Mahmudul Khan, Deepika S. Darbari, Arthur L. Burnett
Publikováno v:
Blood. 140:1636-1638
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ffb99853585245a72c89f832e2056be
https://doi.org/10.1182/blood-2022-157004
https://doi.org/10.1182/blood-2022-157004